Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

Kallikrein-Related Peptidase 13 (KLK13) (Middle Region) Peptide

KLK13 Reactivité: Humain Hôte: Synthetic WB, BP
N° du produit ABIN979076
  • Antigène Tous les produits Kallikrein 13 (KLK13)
    Kallikrein 13 (KLK13) (Kallikrein-Related Peptidase 13 (KLK13))
    Protein Region
    Middle Region
    Origine
    Humain
    Source
    • 3
    Synthetic
    Application
    Western Blotting (WB), Blocking Peptide (BP)
    Séquence
    VLTAAHCLKE GLKVYLGKHA LGRVEAGEQV REVVHSIPHP EYRRSPTHLN
    Attributs du produit
    This is a synthetic peptide designed for use in combination with anti-KLK13 Antibody(ARP55295_P050),. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
    Purification
    Purified
  • Indications d'application
    Each Investigator should determine their own optimal working dilution for specific applications.
    Restrictions
    For Research Use only
  • Format
    Lyophilized
    Reconstitution
    Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
    Concentration
    1 mg/mL
    Buffer
    Final peptide concentration is 1 mg/mL in PBS.
    Conseil sur la manipulation
    Avoid repeated freeze-thaw cycles.
    Stock
    -20 °C
    Stockage commentaire
    For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
  • Antigène
    Kallikrein 13 (KLK13) (Kallikrein-Related Peptidase 13 (KLK13))
    Synonymes
    KLK-L4 Peptide, KLKL4 Peptide, Egfbp-2 Peptide, mGk-13 Peptide, kallikrein related peptidase 13 Peptide, kallikrein related-peptidase 13 Peptide, KLK13 Peptide, Klk13 Peptide
    Sujet
    Kallikreins are a subgroup of serine proteases having diverse physiological functions. Growing evidence suggests that many kallikreins are implicated in carcinogenesis and some have potential as novel cancer and other disease biomarkers. This gene is one of the fifteen kallikrein subfamily members located in a cluster on chromosome 19. Expression of this gene is regulated by steroid hormones and may be useful as a marker for breast cancer. An additional transcript variant has been identified, but its full length sequence has not been determined.

    Alias Symbols: DKFZP586J1923, KLK-L4, KLKL4

    Protein Interaction Partner: SERPINF2,A2M,SERPINA1

    Protein Size: 277
    Poids moléculaire
    29 kDa
    ID gène
    26085
    NCBI Accession
    NM_015596, NP_056411
    UniProt
    Q9UKR3
Vous êtes ici:
Support technique